Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-25-005352

Chief Financial Officer acquired 32,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MARIANI PETER J Chief Financial Officer 2025-01-17 Option exercise +32,625 $1.00 $32,625 433,988 D
Derivatives
MARIANI PETER J Chief Financial Officer 2025-01-17 Option exercise · Subscription Rights (right to buy) −32,625 0 D
MARIANI PETER J Chief Financial Officer 2025-01-17 Other acquisition · Series A Right Warrants +32,625 32,625 D
MARIANI PETER J Chief Financial Officer 2025-01-17 Other acquisition · Series B Right Warrants +32,625 32,625 D
Loading xslF345X05/tm254168-6_4seq1.xml…